Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension.
What is Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension used for?
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP (amoxicillin/clavulanate potassium) and other antibacterial drugs, Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*: 1.1 Lower Respiratory Tract Infections - caused by beta-lactamase-producing isolates of Haemophilus influenzae and Moraxella catarrhalis. 1.2 Acute Bacterial Otitis Media - caused by beta-lactamase-producing isolates of H. influenzae and M. catarrhalis. 1.3 Sinusitis - caused by beta-lactamase-producing isolates of H. influenzae and M. catarrhalis. 1.4 Skin and Skin Structure Infections - caused by beta-lactamase-producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species. 1.5 Urinary Tract Infections - caused by beta-lactamase-producing isolates of E. coli, Klebsiella species, and Enterobacter species. 1.6 Limitations of Use - When susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP should not be used.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP (amoxicillin/clavulanate potassium) and other antibacterial drugs, Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*: 1.1 Lower Respiratory Tract Infections - caused by beta-lactamase-producing isolates of Haemophilus influenzae and Moraxella catarrhalis. 1.2 Acute Bacterial Otitis Media - caused by beta-lactamase-producing isolates of H. influenzae and M. catarrhalis. 1.3 Sinusitis - caused by beta-lactamase-producing isolates of H. influenzae and M. catarrhalis. 1.4 Skin and Skin Structure Infections - caused by beta-lactamase-producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species. 1.5 Urinary Tract Infections - caused by beta-lactamase-producing isolates of E. coli, Klebsiella species, and Enterobacter species. 1.6 Limitations of Use - When susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP should not be used.
Is Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension safe to use while breastfeeding? Can it interfere with growth and development of my kid?
There are 2 main ingredients of Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension, Amoxicillin anhydrous and Clavulanic acid. One by one we have analyzed both Amoxicillin anhydrous and Clavulanic acid for its impact on breastfeeding and based on our analysis we can conclude that Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension is safe to use in breastfeeding. We recommend you to check our analysis of Amoxicillin anhydrous and Clavulanic acid as below.
Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension Breastfeeding Analsys
SafeCAS Number: 26787-78-0
Excretion into breast milk is insignificant and no adverse effects reported in breasted infants. Es considerada medicación compatible con la lactancia por autores y sociedades científicas relevantes (Rowe 2013, Nahum 2006, Mahadevan 2006, Bar-Oz 2003, CDC 2001, Fulton 1992). Es una medicación de uso común en Pediatría y considerado medicamento esencial para uso pediátrico por la OMS (WHO 2013). The possible negativity of cultures in febrile infants whose mothers take antibiotics should be taken into account, as well as the possibility of gastroenteritis due to altered intestinal flora (Benyamini 2005, Ito 1993, Kafetzis 1981). American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002).
Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension Breastfeeding Analsys - 2
CAS Number: 26787-78-0
Limited information indicates that amoxicillin produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Occasionally, rash and disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush, have been reported, but these effects have not been adequately evaluated. Amoxicillin is acceptable in nursing mothers. Amoxicillin powder for suspension reconstituted with breastmilk is absorbed as well as the powder reconstituted with water.[1]
CAS Number: 86482-18-0
Limited information indicates that ticarcillin produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Clavulanic acid has not been studied in nursing mothers. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with penicillins, but these effects have not been adequately evaluated. Ticarcillin and clavulanic acid is acceptable is acceptable in nursing mothers.
Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension Breastfeeding Analsys - 3
Clavulanic acid and Breastfeeding
Safe
I already used Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension and meanwhile I breastfed my baby should I be concerned?
It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension and have used it then do not panic as Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension is mostly safe in breastfeeding and should not cause any harm to your baby.
My health care provider has asked me to use Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension, what to do?
Usage of Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension is safe for nursing mothers and baby, No worries.
If I am using Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension, will my baby need extra monitoring?
No
Who can I talk to if I have questions about usage of Augmentin | Amox/clav.pot.oral Susp Powder, For Suspension in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week
Drug Brands with same Active ingredients